Showing results (1-10 of 367) with videos related to
Sort By:
Pageof 37
Acta Diabetologica|September 28, 2011
Efficacy of renin-angiotensin system (RAS) blockers on cardiovascular and renal outcomes in patients with type 2 diabetesZemin Cao, Mark E CooperJournal of Diabetes Investigation|May 21, 2014
Pathogenesis of diabetic nephropathyZemin Cao, Mark E CooperDiabetes Technology & Therapeutics|August 8, 2002
Combination antihypertensive therapy in the treatment of diabetic nephropathyGeoffrey Boner, Zemin Cao, Mark E CooperHypertension (Dallas, Tex. : 1979)|January 14, 2004
Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptorsXiaoli Zhang, Markus Lassila, Mark E Cooper, et al.Kidney International|August 26, 2004
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetesGuorong Ma, Terri J Allen, Mark E Cooper, et al.Journal of the American Society of Nephrology : JASN|November 26, 2003
Increased renal vascular endothelial growth factor and angiopoietins by angiotensin II infusion is mediated by both AT1 and AT2 receptorsBishoy Rizkalla, Josephine M Forbes, Mark E Cooper, et al.Journal of Hypertension|January 12, 2005
Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin systemBishoy Rizkalla, Josephine M Forbes, Zemin Cao, et al.Genes|April 9, 2014
Role of Cell Division Autoantigen 1 (CDA1) in Cell Proliferation and FibrosisBan-Hock Toh, Yugang Tu, Zemin Cao, et al.Kidney International|July 9, 2003
Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetesJie Qin, Zhili Zhang, Jie Liu, et al.Journal of Hypertension|January 25, 2003
Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrinBelinda J Davis, Zemin Cao, Marc de Gasparo, et al.Pageof 37